Drupal.behaviors.print = function(context) {window.print();window.close();}>
Complete Genomics Nets $47M in IPO at $9 per Share
November 16, 2010
Complete Genomics Nets $47M in IPO at $9 per Share
The IPO share price was well below the company's most recent target of $12 to $14 per share
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Complete Genomics Offers 4.5M Shares of Common Stock; Signs $20M Loan Agreement
May 17, 2011 / In Sequence
Complete Genomics Closes $39M Funding Round, Vows to 'Vigorously Defend' Against Illumina Suit
August 24, 2010 / In Sequence
Complete Genomics Signs Two Contracts Worth $14M as Falling Prices Impact Q2 Revenues
August 9, 2011 / In Sequence
Paired Ends
June 28, 2011 / In Sequence
Complete Genomics Sees Future in Cancer Genome Sequencing; Plans New Cancer-Specific Product
March 16, 2011 / Clinical Sequencing News